{"title":"TGF‐β receptors: Assembly, signalling, and disease relevance","authors":"M. S. Krishnaveni, O. Eickelberg","doi":"10.1002/SITA.200600065","DOIUrl":"https://doi.org/10.1002/SITA.200600065","url":null,"abstract":"TGF-β superfamily members exert their biological effects by binding to type I, type II and type III cell surface receptors. While the type I and type II receptors entail serine/threonine kinase domains and form signalling entities upon ligand binding, the type III receptors represent accessory receptors with no discernible kinase function identified to date. In TGF-β signalling, a heterotetrameric complex of the type I and II receptors is induced upon ligand binding, which promotes signal transduction through intracellular Smad proteins. Recent studies have indicated that type I and type II oligomerisation dynamics, which mainly serve to promote signalling purposes of TGF-β ligands, can also exert functional antagonism and negative regulation of ligand-induced signalling. The purpose of this review is to supply a detailed description of the TGF-β ligand-receptor network and oligomerisation patterns induced thereby, with special emphasis on the emerging and non-redundant roles of the accessory receptors of the TGF-β ligands in modulating receptor assembly and biological effects.","PeriodicalId":88702,"journal":{"name":"Signal transduction","volume":"71 3-4","pages":"301-313"},"PeriodicalIF":0.0,"publicationDate":"2006-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1002/SITA.200600065","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"50950747","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Yin and Yang in BMP signaling: Impact on the pathology of diseases and potential for tissue regeneration","authors":"A. Hartung, Christina Sieber, P. Knaus","doi":"10.1002/SITA.200600098","DOIUrl":"https://doi.org/10.1002/SITA.200600098","url":null,"abstract":"Bone morphogenetic proteins (BMPs) are multi-functional growth factors belonging to the transforming growth factor β (TGFβ) superfamily. BMPs are expressed in a large variety of tissues and organs, where they exhibit pleiotropic functions during development as well as in the adult organism. Thus maintenance of the BMP signaling pathways requires strict control and regulation by antagonists, co-receptors and inhibitors. BMPs exert their signals by binding to hetero-oligomeric signaling complexes composed of type I and type II receptors with serine/threonine kinase activity. They play a decisive role in the development of several diseases but are also involved in self-renewal of stem cells and tissue regeneration. These insights may lead to the design of future therapeutic treatments. This review focuses on the differential BMP signaling pathways initiated at distinct oligomerized signaling complexes as well as on the pathological aspects of BMP signaling in diseases and their potential for tissue regeneration.","PeriodicalId":88702,"journal":{"name":"Signal transduction","volume":"133 8","pages":"314-328"},"PeriodicalIF":0.0,"publicationDate":"2006-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1002/SITA.200600098","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"50951163","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Antioxidants and inhibitors of flavoprotein-dependent oxidases abrogate TGF-beta induction of biglycan: Evidence for a role of reactive oxygen species","authors":"H. Ungefroren, S. Groth, F. Fändrich","doi":"10.1002/SITA.200600100","DOIUrl":"https://doi.org/10.1002/SITA.200600100","url":null,"abstract":"Transforming growth factor-beta (TGF-β) in excess evokes inflammation, fibrosis, and desmoplasia in part by stimulating extracellular matrix synthesis including expression of the small leucine-rich proteoglycan biglycan (Bgn). Since TGF-β exerts some of its effects by stimulating the generation of reactive oxygen species (ROS) in cells, we investigated the possibility that ROS signaling is involved in Bgn induction by TGF-β. In pancreatic carcinoma PANC-1 cells, antioxidants (N-acetyl-L-cysteine, ascorbic acid), ROS scavengers (Tiron) and inhibitors of flavoprotein-dependent oxidases such as the ROS producing enzyme NADPH oxidase (apocynin and diphyleneiodonium) all inhibited TGF-β1-induced Bgn expression. In agreement with a role of the transcription factor NFκB in ROS cellular actions, the NFκB inhibitor pyrrolidinecarbodithiocarbamate also reduced the TGF-β effect on Bgn, while S-M-sulfate, an inhibitor of the nitric oxide-generating enzyme iNOS was ineffective in this respect. TGF-β time-dependently and moderately induced ROS production that was suppressed by diphenyleneiodonium. RT-PCR revealed that PANC-1 cells expressed various subunits of NADPH oxidase, namely p22phox, p47phox and p67phox as well as Nox isoforms 2, 4, 5 and 6, but lacked mRNA for Nox1 and 3. Blocking TGF-β-induced Bgn expression by modulating cellular redox status could have beneficial effects on fibrotic disorders caused by TGF-β hyperactivity.","PeriodicalId":88702,"journal":{"name":"Signal transduction","volume":"133 S2","pages":"338-344"},"PeriodicalIF":0.0,"publicationDate":"2006-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1002/SITA.200600100","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"50951195","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Updating interleukin-6 classic- and trans-signaling","authors":"J. Scheller, J. Grötzinger, S. Rose-John","doi":"10.1002/SITA.200600086","DOIUrl":"https://doi.org/10.1002/SITA.200600086","url":null,"abstract":"The cytokine interleukin-6 has been identified and cloned among others as B-cell stimulatory factor, hepatocyte stimulating factor, plasmacytoma growth factor, and interferon beta-2. Consequently, it emerged, that IL-6 controls a huge variety of cellular functions, among them induction of the acute phase response in the liver, mediation of inflammation and malignant transformation. In this review, we summarize the so called classical IL-6 signaling, which is mediated by the complex of IL-6, the membrane bound IL-6R and two gp130 molecules, and an alternative pathway called trans-signaling, which apparently contributes to the development of chronic inflammation and cancer. During trans-signaling an agonistic soluble IL-6R is generated, which sensitizes cells lacking the membrane bound IL-6R. Finally, we discuss specific inhibition of IL-6-trans-signaling processes by a naturally occurring soluble form of gp130, demonstrating that this protein may emerge as an important future therapeutic in clinical applications for chronic inflammation.","PeriodicalId":88702,"journal":{"name":"Signal transduction","volume":"65 12","pages":"240-259"},"PeriodicalIF":0.0,"publicationDate":"2006-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1002/SITA.200600086","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"50950834","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"TGF-β/Smad-signaling in liver cells: Target genes and inhibitors of two parallel pathways","authors":"K. Breitkopf, H. Weng, S. Dooley","doi":"10.1002/SITA.200600097","DOIUrl":"https://doi.org/10.1002/SITA.200600097","url":null,"abstract":"Transforming growth factor (TGF)-β is a major mediator of fibrosis in diverse organs/tissues, including liver, due to its gene regulatory properties that lead to high expression and secretion of extracellular matrix components. Whereas the canonical Smad pathway seems to be very simple, TGF-β turns out to be a multiplicity factor with a highly cell type specific outcome and therefore, no universally valid plan of its signal transduction can be formulated. In the present review, we will summarize information about the Smad dependent and Smad independent TGF-β signaling network in hepatic stellate cells (HSCs) and hepatocytes, with emphasis on its role in chronic liver disease. In addition, current state of the art anti-TGF-β strategies for liver fibrosis treatment are discussed.","PeriodicalId":88702,"journal":{"name":"Signal transduction","volume":"68 4","pages":"329-337"},"PeriodicalIF":0.0,"publicationDate":"2006-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1002/SITA.200600097","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"50951150","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Ting Wang, Chihiro Kondo, K. Yamashita, M. Oguchi, K. Iwata, T. Noguchi, T. Hayakawa
{"title":"Concentration-dependent stimulation by tissue inhibitor of metalloproteinases(TIMP)-2 of two signaling pathways in human osteosarcoma (MG-63) Cells","authors":"Ting Wang, Chihiro Kondo, K. Yamashita, M. Oguchi, K. Iwata, T. Noguchi, T. Hayakawa","doi":"10.1002/SITA.200500080","DOIUrl":"https://doi.org/10.1002/SITA.200500080","url":null,"abstract":"We reported previously that tyrosine kinase (TYK) and mitogen-activated protein kinase (MAPK) play a role in TIMP-dependent growth signaling. Here we demonstrate that the activation of MAPK stimulated by TIMP-2 was sharply inhibited in MG-63 cells by PP1, a selective inhibitor of Src-family tyrosine kinases, suggesting that Src activation is possibly required for the MAPK activity in response to 1 ng/mL TIMP-2. A specific cell-permeable inhibitor of MAPK kinase (MEK), PD 98058 had an inhibitory effect on MAPK activity, indicating that MEK is an upstream effector of MAPK. By transfecting MG-63 cells with dominant-negative Ras, RasN17, and furthermore, by using a selective farnesyltransferase inhibitor, FTI-277, we found that MAPK activation stimulated by TIMP-2 was independent of Ras. We also demonstrated that the activation of MAPK in response to 1 ng/mL TIMP-2 was inhibited by a cAMP agonist, 8-bromo-cAMP. On the contrary, [3H]thymidine incorporation and the activation of MAPK, all of which were heavily suppressed by increasing the TIMP-2 concentration up to 100 ng/mL, were recovered by the addition of a cell-permeable specific PKA inhibitor, H-89. These results strongly suggest the presence of a negative crosstalk from the cAMP/PKA pathway to the TYK/MAPK one.","PeriodicalId":88702,"journal":{"name":"Signal transduction","volume":"2 9","pages":"280-286"},"PeriodicalIF":0.0,"publicationDate":"2006-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1002/SITA.200500080","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"50950597","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Moving on: Molecular mechanisms in TGFβ‐induced epithelial cell migration","authors":"K. Giehl, A. Menke","doi":"10.1002/SITA.200600094","DOIUrl":"https://doi.org/10.1002/SITA.200600094","url":null,"abstract":"TGFβ, particularly TGFβ1-3, has been shown to promote epithelial dedifferentiation or epithelial-mesenchymal transition (EMT). While inhibition of epithelial cell proliferation in response to TGFβ is mainly mediated by the well-characterised Smad-pathway and subsequent regulation of gene transcription, the molecular mechanisms leading to TGFβ-induced migration, invasion and metastasis of epithelial tumour cells are less clear. Recent results from several groups suggest that the gain of tumourigenic activity by TGFβ includes signalling by mitogen-activated protein kinases (MAP kinases), phosphatidylinositol 3-kinase (PI3-K) and Rho-GTPases. Activation of the MAP kinases extracellular signal-regulated kinase (ERK) 1 and 2, p38 as well as c-jun N-terminal kinase (JNK) has been identified as important steps in TGFβ-induced, Smad4-independent signal transduction in epithelial cells. A role of activated ERK and JNK and their association with focal complexes in TGFβ-induced cell migration and actin cytoskeleton reorganisation of carcinoma cells has been identified recently. In this review we will focus on new data about the molecular mechanisms involved in the TGFβ-induced Smad-independent regulation of epithelial cell migration.","PeriodicalId":88702,"journal":{"name":"Signal transduction","volume":"1 1","pages":"355-364"},"PeriodicalIF":0.0,"publicationDate":"2006-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1002/SITA.200600094","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"50951120","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Recent advances in TGFβ‐regulated transcription during carcinogenesis","authors":"Anita Buck, V. Ellenrieder","doi":"10.1002/SITA.200600093","DOIUrl":"https://doi.org/10.1002/SITA.200600093","url":null,"abstract":"The multifunctional activities of transforming growth factor-beta (TGFβ) endow it with both tumor suppressor and tumor promoting activities, depending on the stage of carcinogenesis and the cellular activation state. In early tumor stages, TGFβ inhibits epithelial cell growth through induction of apoptosis and transcriptional regulation of cell cycle controlling genes. During tumor progression, however, many cancer cells escape from TGFβ-induced growth inhibition and, instead, respond to TGFβ with increased malignancy. TGFβ stimulates tumor promotion particularly in those tumor cells in which Smad-signaling remains functional and through transcriptional regulation of gene expression. Thus, loss of sensitivity to growth inhibition by TGFβ is not synonymous with complete loss of TGFβ signaling. Rather, it suggests that tumor cells gain advantage by selective inactivation of TGFβ tumor suppressor activities while retaining its tumor promoting functions. In this review we focus on novel aspects in TGFβ signaling and transcription and in particular on the role of Smad-interacting transcription factors. We also summarize recent advances in both cytoplasmic and nuclear crosstalk mechanisms between Smad and non-Smad signaling pathways and how this interaction results in the fine-tuning of Smad-mediated transcription during cancer progression. This knowledge will help to better understand the molecular mechanisms responsible for the switch of TGFβ from a tumor suppressor to a tumor promotor.","PeriodicalId":88702,"journal":{"name":"Signal transduction","volume":"30 2","pages":"345-354"},"PeriodicalIF":0.0,"publicationDate":"2006-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1002/SITA.200600093","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"50951108","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Oligonucleotide microarrays for studying the effects of Ras signal transduction on the genetic program","authors":"O. Tchernitsa, C. Sers, A. Geflitter, R. Schäfer","doi":"10.1002/SITA.200600090","DOIUrl":"https://doi.org/10.1002/SITA.200600090","url":null,"abstract":"Cytoplasmic signal transduction processes are tightly coupled with the transcriptional regulation of genes executing cellular phenotypes in normal conditions and in disease. A major challenge in signal transduction research is to understand how the specificity of the transcriptional response is determined by complex networks of signaling effectors and transcription factors. The Ras signal transduction pathway belongs to the few characterized pathways triggering malignant phenotypes both in experimental and human cancer. We have developed an array-based tool which permits analysis of Ras signaling on transcription under various experimental conditions as well as in tumor specimens. The composition of targets represented on the Ras signaling target array (RASTA) is based on previously validated gene expression profiles and published functional studies. The Ras signaling target array was used to compare the transcriptional response toward oncogenic Ras in fibroblasts and epithelial cells and to assess the time-dependent deregulation of target genes.","PeriodicalId":88702,"journal":{"name":"Signal transduction","volume":"57 5","pages":"209-218"},"PeriodicalIF":0.0,"publicationDate":"2006-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1002/SITA.200600090","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"50950980","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Protein‐protein interaction screening with the Ras‐recruitment system","authors":"C. Kruse, S. Hanke, S. Vasiliev, H. Hennemann","doi":"10.1002/SITA.200600089","DOIUrl":"https://doi.org/10.1002/SITA.200600089","url":null,"abstract":"The fast paced progress in genomics yielded a multitude of novel identified genes. Therefore reliable and up scalable methods are required to identify the functions of the encoded proteins. By using protein-protein interaction screening technologies, the function of many proteins has successfully been assigned, and proved in combination with other techniques. We describe the application of an in vivo screening system for protein-protein interactions, the Ras-recruitment system (RRS). The RRS has been used extensively to identify novel interaction partners, also in cases where common systems failed. Therefore we propose the RRS as a valuable alternative interaction screening method that can widely be used among protein classes and that has been further developed by our group into a high-throughput screening system.","PeriodicalId":88702,"journal":{"name":"Signal transduction","volume":"48 1","pages":"198-208"},"PeriodicalIF":0.0,"publicationDate":"2006-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1002/SITA.200600089","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"50950924","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}